V
Viking Therapeutics (VKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Viking Therapeutics (VKTX)
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Company's clinical program, VK5211, is an orally available drug candidate, which i... Read more
- USD64.54
- USD65.80
- USD61.64
- USD99.41
- 2.10%
- --
- 3.06M
- 3.91M
- 7.6B
- 8.28
- 217.30%
Stock News
3 hours ago
Apple Has Been Left Behind in the AI Rally. Why It Might One Day Still Be the Big Winner.
Yahoo
yesterday
Cramer’s week ahead: Earnings from Tesla, Merck and Big Tech
CNBC
yesterday
TV and film jobs may never fully recover post-pandemic, strikes, says Teamsters president
CNBC
yesterday
KKR Real Estate Finance Trust Inc. Declares Preferred Stock Dividend
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
